Development of novel drugs for autoimmune disease, based on the binding molecules of &#945;9 integrin variant SF&#945;9

Naoki Matsumoto; Takuya Nakatsuru; Tomoe Miyashita; Shigeyuki Kon; Tadashi Matsuda

4:45 PM - 6:45 PM

[1P0081] Development of novel drugs for autoimmune disease, based on the binding molecules of α9 integrin variant SFα9

〇Naoki Matsumoto¹, Takuya Nakatsuru¹, Tomoe Miyashita¹, Shigeyuki Kon¹, Tadashi Matsuda¹ (1.Dept. of Immunol., Faculty of Pharm. Sci., Hokkaido Univ.)

α9 integrin, XCL1, Autoimmune diseases, Cell migration, Cell adhesion

This archive has moved to the member page of The Molecular Biology Society of Japan and The Japanese Biochemical Society.
Members of the either society can access the abstracts via links at the member page of the sites.
Please feel free to contact the journal offices for any inquiries.

BMB2015 Biochemistry and Molecular Biology

[1P0081] Development of novel drugs for autoimmune disease, based on the binding molecules of α9 integrin variant SFα9

Password